Rudy Dekeyzer

Dr. Rudy Dekeyser is Partner at LSP, a leading European venture capital firm with 2 billion Euro under management and investing in healthcare companies from seed to late stage in the fields of drug discovery, drug development, medical devices, diagnostics and digital health. Prior to joining LSP in 2012, Rudy has been managing director of VIB, an entrepreneurial life sciences research institute which he co-founded with Jo Bury in 1995. Rudy has also been intimately involved in the foundation of several bio-incubators, bio-accelerators, the European Association of Science and Technology Managers and Oncode, a Dutch research institute in the field of cancer. Rudy has been/is chairman/non-executive director at Ablynx (acquired by Sanofi), Actogenix (acquired by Intrexon), Multiplicom (acquired by Agilent), CropDesign (acquired by BASF), Devgen (acquired by Syngenta), QBiologicals (acquired by Amatsi), Curetis (listed), Sequana Medical (listed), Celyad (listed) and Lumeon and is also chairman/board member of several non-profit life sciences initiatives such as EMBLEM, De Weijerhorst Stichting, Fonds Généret and the Fonds Fournier-Majoie.

May 27, 2020 Studying the development of ovarian cancer wi... Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of hig... read more
May 26, 2020 HUB Patient-Derived Organoids added to CrownB... San Diego, Calif – May 19, 2020 — Crown Bioscience today announced the expansion of their unique organoid platform w... read more
May 13, 2020 Hormone-producing cells in the human gut are difficult to study, as they are very rare and unique to different species o... read more